Literature DB >> 16370335

Cell transplantation for patients with Parkinson's disease.

G Paul1.   

Abstract

This chapter focuses on cell replacement therapies in Parkinson's disease (PD) and describes experimental data leading to clinical trials, as well as the methodology and efficacy of grafts of human embryonic nigral tissue in patients with PD. It also highlights some of the clinical problems the procedure presents and considers future alternative sources of donor tissue, including various forms of stem cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16370335

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  2 in total

1.  Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.

Authors:  Mohamed Salama; Mahmoud Sobh; Mahmoud Emam; Ahmed Abdalla; Dina Sabry; Mohamed El-Gamal; Ahmed Lotfy; Mahmoud El-Husseiny; Mohamed Sobh; Ali Shalash; Wael My Mohamed
Journal:  Exp Ther Med       Date:  2017-01-20       Impact factor: 2.447

2.  Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease.

Authors:  Sonya Carvalho Neto; Ahmad Salti; Zoe Puschban; Nadia Stefanova; Roxana Nat; Georg Dechant; Gregor K Wenning
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.